中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Return - Others
2025-04-24
Next Day Disclosure Return - Others
2025-04-23
Inside Information - Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-Week Phase IIa Study Protocol to FDA
2025-04-23
Next Day Disclosure Returns - Share Buyback/Others
2025-04-17
Next Day Disclosure Returns - Share Buyback/Others
2025-04-16
Next Day Disclosure Return - Others
2025-04-15
Next Day Disclosure Return - Others
2025-04-14
Next Day Disclosure Returns - Share Buyback/Others
2025-04-11
Next Day Disclosure Returns - Share Buyback/Others
2025-04-10
Next Day Disclosure Returns - Share Buyback
2025-04-09
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1